PDS Biotechnology Corporation (PDSB) Free cash flow 2016–2025
PDS Biotechnology Corporation (PDSB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.8MFY2025 · since FY2016: -$32.9M → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +20.8% |
| FY2024 | -$35.1M | -4.2% |
| FY2023 | -$33.6M | — |
| FY2018 | -$1.6M | +96.2% |
| FY2017 | -$40.9M | -24.4% |
| FY2016 | -$32.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PDSB financial trends
PDSB RevenuePDSB Net incomePDSB Net marginPDSB Gross profitPDSB Gross marginPDSB Operating incomePDSB Operating marginPDSB Operating cash flowPDSB Capital expendituresPDSB Return on equityPDSB Stock buybacksPDSB Dividends paidPDSB Total assetsPDSB Total liabilitiesPDSB Shareholders’ equityPDSB overview →